Loading…
Jenburkt Pharmaceuticals (JENBURPH)₹953.75−2.08%Pharmaceuticals
At the end of the Jun 2026 quarter, Jenburkt Pharmaceuticals' shareholders were: promoters 46.63%, DIIs 0.12%, public 53.25%. Promoter holding is down 0.02 percentage points from 46.65% a quarter earlier. 0.00% of promoter shares were pledged. It had 7,100 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 47.43% | 47.40% | 47.24% | 46.72% | 46.72% | 46.70% | 46.69% | 46.68% | 46.67% | 46.66% | 46.65% | 46.63% |
| FIIs | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
| Public | 51.20% | 52.60% | 52.76% | 53.28% | 53.28% | 53.18% | 53.19% | 53.20% | 53.21% | 53.22% | 53.23% | 53.25% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 5,870 | 6,019 | 6,314 | 6,417 | 6,626 | 6,898 | 6,984 | 6,710 | 6,853 | 7,160 | 6,996 | 7,100 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ashish Uttam Bhuta | Promoter | 18.08% | 0.00 |
| Bhuta Holdings Private Limited | Promoter | 13.93% | 0.00 |
| Kalindi Hemendra Bhuta | Promoter | 9.10% | 0.00 |
| Nirmala Vinodkumar Daga | Public | 3.33% | 0.00 |
| Investor Education And Protection Fund Authority | Public | 2.34% | −0.02 |
| Ranjeet Singh Sibia | Public | 1.51% | 0.00 |
| Optirational Ventures Llp | Public | 1.21% | New |
| Bhavika Ashish Bhuta | Promoter | 1.18% | 0.00 |
| Kunti Ketan Gala | Promoter | 1.17% | 0.00 |
| Rajiv Garg | Public | 1.08% | 0.00 |
| Sushila Paraskumar Daga | Public | 1.06% | 0.00 |
| Parshva Kumar Daga | Public | 1.04% | 0.00 |
| Kaushik Daga | Public | 1.03% | 0.00 |
| Varun Daga | Public | 1.02% | 0.00 |
| Bharath C Jain | Public | 1.01% | 0.00 |
| Asha Mahesh Bhuta | Promoter | 0.85% | 0.00 |
| Riddhi Haresh Shroff | Promoter | 0.73% | 0.00 |
| Mahesh Harshad Bhuta | Promoter | 0.68% | 0.00 |
| Jagruti Ketan Bhuta | Promoter | 0.54% | −0.02 |
| Shivani Haresh Shroff | Promoter | 0.39% | 0.00 |
| Prakash H Bhuta | Promoter | 0.00% | 0.00 |
Promoters held 46.63% of Jenburkt Pharmaceuticals at the end of the Jun 2026 quarter, down 0.05 percentage points from 46.68% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.12% (unchanged at 0.12% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Jenburkt Pharmaceuticals had 7,100 shareholders at the end of the Jun 2026 quarter, against 6,710 a year earlier.
Nirmala Vinodkumar Daga (Public) held 3.33% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.